Bas D. Koster

567 total citations
19 papers, 406 citations indexed

About

Bas D. Koster is a scholar working on Immunology, Oncology and Genetics. According to data from OpenAlex, Bas D. Koster has authored 19 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 11 papers in Oncology and 2 papers in Genetics. Recurrent topics in Bas D. Koster's work include Immunotherapy and Immune Responses (12 papers), Cancer Immunotherapy and Biomarkers (9 papers) and CAR-T cell therapy research (8 papers). Bas D. Koster is often cited by papers focused on Immunotherapy and Immune Responses (12 papers), Cancer Immunotherapy and Biomarkers (9 papers) and CAR-T cell therapy research (8 papers). Bas D. Koster collaborates with scholars based in Netherlands, United States and Germany. Bas D. Koster's co-authors include Tanja D. de Gruijl, Alfons J.M. van den Eertwegh, Ekaterina S. Jordanova, A. Marijne Heeren, Rik J. Scheper, Berbel J.R. Sluijter, Mari F.C.M. van den Hout, Barbara G. Molenkamp, Dafni Chondronasiou and Paul A.M. van Leeuwen and has published in prestigious journals such as Blood, Clinical Cancer Research and Cancer Immunology Immunotherapy.

In The Last Decade

Bas D. Koster

19 papers receiving 403 citations

Peers

Bas D. Koster

IMMUN

ONCOL

EPIDE

Joyce M. Lubbers Netherlands

Jossie Rotman Netherlands

Hila Razon Israel

Michael J. Halaška Czechia

Cécile Déjou France

Sheri McMahon United States

Boyeong Song South Korea

Diarmaid D. Houlihan Ireland

Tammy Maxwell Australia

M. N. Stakheyeva Russia

Joyce M. Lubbers Netherlands

Bas D. Koster

338 ×1.2

IMMUN

295 ×1.1

ONCOL

81 ×1.1

22 ×0.7

EPIDE

22 ×0.7

Citations per year, relative to Bas D. Koster Bas D. Koster (= 1×) peers Joyce M. Lubbers

Countries citing papers authored by Bas D. Koster

Since Specialization

Citations

This map shows the geographic impact of Bas D. Koster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bas D. Koster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bas D. Koster more than expected).

Fields of papers citing papers by Bas D. Koster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bas D. Koster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bas D. Koster. The network helps show where Bas D. Koster may publish in the future.

Co-authorship network of co-authors of Bas D. Koster

This figure shows the co-authorship network connecting the top 25 collaborators of Bas D. Koster. A scholar is included among the top collaborators of Bas D. Koster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bas D. Koster. Bas D. Koster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Fransen, Marieke F., Bas D. Koster, Anita G.M. Stam, et al.. (2022). Local delivery of low-dose anti–CTLA-4 to the melanoma lymphatic basin leads to systemic T _reg reduction and effector T cell activation. Science Immunology. 7(73). eabn8097–eabn8097. 31 indexed citations

Koster, Bas D., Mari F.C.M. van den Hout, Annelies W. Turksma, et al.. (2021). T cell infiltration on local CpG-B delivery in early-stage melanoma is predominantly related to CLEC9A⁺CD141⁺ cDC1 and CD14⁺ antigen-presenting cell recruitment. Journal for ImmunoTherapy of Cancer. 9(3). e001962–e001962. 18 indexed citations

Koster, Bas D., Saskia J. Santegoets, Arnold Baars, et al.. (2019). Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial. Cancer Immunology Immunotherapy. 68(6). 1025–1035. 19 indexed citations

Rotman, Jossie, Bas D. Koster, Ekaterina S. Jordanova, A. Marijne Heeren, & Tanja D. de Gruijl. (2019). Unlocking the therapeutic potential of primary tumor-draining lymph nodes. Cancer Immunology Immunotherapy. 68(10). 1681–1688. 57 indexed citations

Koster, Bas D., Mari F.C.M. van den Hout, Berbel J.R. Sluijter, et al.. (2019). In the mix: the potential benefits of adding GM-CSF to CpG-B in the local treatment of patients with early-stage melanoma. OncoImmunology. 9(1). 1708066–1708066. 7 indexed citations

Koster, Bas D., Mari F.C.M. van den Hout, Berbel J.R. Sluijter, et al.. (2017). Local Adjuvant Treatment with Low-Dose CpG-B Offers Durable Protection against Disease Recurrence in Clinical Stage I–II Melanoma: Data from Two Randomized Phase II Trials. Clinical Cancer Research. 23(19). 5679–5686. 54 indexed citations

Hout, Mari F.C.M. van den, Bas D. Koster, Berbel J.R. Sluijter, et al.. (2017). Melanoma Sequentially Suppresses Different DC Subsets in the Sentinel Lymph Node, Affecting Disease Spread and Recurrence. Cancer Immunology Research. 5(11). 969–977. 37 indexed citations

Sluijter, Berbel J.R., Mari F.C.M. van den Hout, Bas D. Koster, et al.. (2015). Arming the Melanoma Sentinel Lymph Node through Local Administration of CpG-B and GM-CSF: Recruitment and Activation of BDCA3/CD141+ Dendritic Cells and Enhanced Cross-Presentation. Cancer Immunology Research. 3(5). 495–505. 50 indexed citations

Koster, Bas D., Tanja D. de Gruijl, & Alfons J.M. van den Eertwegh. (2015). Recent developments and future challenges in immune checkpoint inhibitory cancer treatment. Current Opinion in Oncology. 27(6). 482–488. 23 indexed citations

10.

Heeren, A. Marijne, Bas D. Koster, Sanne Samuels, et al.. (2014). High and Interrelated Rates of PD-L1+CD14+ Antigen-Presenting Cells and Regulatory T Cells Mark the Microenvironment of Metastatic Lymph Nodes from Patients with Cervical Cancer. Cancer Immunology Research. 3(1). 48–58. 95 indexed citations

11.

Heeren, A. Marijne, Bas D. Koster, Sanne Samuels, et al.. (2014). High and interrelated rates of CD14+PD-L1+ antigen-presenting cells and regulatory T cells mark the microenvironment of metastatic lymph nodes from patients with cervical cancer. 5. 1 indexed citations

12.

Hout, Mari F.C.M. van den, Bas D. Koster, Rik J. Scheper, et al.. (2013). Pre-operative intradermal administration of CpG-B ± GM-CSF in stage I-III melanoma patients arms the sentinel lymph node: evidence for reduced tumor spread. Journal for ImmunoTherapy of Cancer. 1(Suppl 1). P92–P92. 1 indexed citations

13.

Hout, Mari F.C.M. van den, Bas D. Koster, Berbel J.R. Sluijter, et al.. (2012). Response: Breslow thickness and excision interval affect the activation state of Langerhans cells in melanoma sentinel lymph nodes. Blood. 119(20). 4809–4810. 3 indexed citations

14.

Mayer, Jean, et al.. (1993). [Hemoglobin SD disease].. PubMed. 141(9). 708–10. 1 indexed citations

15.

Koster, Bas D., et al.. (1991). [Fatal poisoning caused by aconite monk's hood (Aconitum napellus)].. PubMed. 139(6). 366–7. 4 indexed citations

16.

Koster, Bas D., et al.. (1987). Neurenterische Zyste des Mediastinums - Fallbericht und Literaturübersicht. Klinische Pädiatrie. 199(1). 1–8. 2 indexed citations

17.

Bode, U., et al.. (1986). [Acute encephalopathy following cranial irradiation of previously treated meningeal leukemia].. PubMed. 162(10). 618–20. 1 indexed citations

18.

Koster, Bas D., et al.. (1985). [Mediastinal liposarcoma in a 14-year-old girl].. PubMed. 133(7). 490–1. 1 indexed citations

19.

Koster, Bas D., et al.. (1985). Akute Isoniazid-Vergiftung. AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie. 20(1). 32–34. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact